Strategic advice to leverage new technologies
Technology is at the heart of nearly every enterprise, enabling new business models and strategies, and serving as the catalyst to industry convergence. Leveraging the right technology can improve business outcomes, providing intelligence and insights that help you make more informed and accurate decisions. From finding patterns in data through data science, to curating relevant insights with data analytics, to the predictive abilities and innumerable applications of AI, to solving challenging business problems with ML, NLP, and knowledge graphs, technology has brought decision-making to a more intelligent level. Keep pace with the technology trends, opportunities, applications, and real-world use cases that will move your organization closer to its transformation and business goals.
Recently Published
In this Advisor, we look at some of the concerns that organizations believe are hindering their customer experience adoption and implementation plans.
How can mHealth support the new challenges and opportunities of telehealth? In this issue of Cutter Business Technology Journal (CBTJ), we present some stimulating articles that illustrate the impact now, and the future direction, of mHealth.
An organization’s business architecture represents the entire scope of what the organization does and the ecosystem in which it operates — at a high level of detail. This makes business architecture uniquely qualified to facilitate collaboration across silos and break them down when appropriate — something that almost no other disciplines or techniques can do. This Advisor shares some examples of why business architecture is so valuable for working across silos.
If the familiar VPNs are not up to the task of supporting the sudden new generation of WFH users, what’s the alternative? Fortunately, there’s a class of products designed specifically for today’s needs: cloud-based remote access software.
With a focus on brain health and neuroscience, Sean Lorenz describes how technology is helping us better assess our brain health journeys with remote detection, diagnosis, and treatment tools. Given the issues surrounding the COVID-19 pandemic, he explores the urgent need that requires the healthcare system to actively look toward telehealth and RPM.
This article moves us up the healthcare value chain by highlighting the impact that COVID-19 has had on clinical trials. Cutter Consortium Senior Consultant Ben van der Schaaf and Pan Xi describe the current state of mHealth along with technology innovations that forward-looking R&D leaders in pharmaceuticals are deploying. Knowing that the current shift will not be temporary, the authors urge healthcare organizations “to adapt and be in the right place at the right time … to prepare for this imminent change.”
Heléne Spjuth examines the economics of mHealth and the resulting challenges and opportunities for all stakeholders in the healthcare ecosystem. In defining the healthcare ecosystem and its various reimbursement models, she shows the “unique circumstances that will serve either as barriers to, or enablers of, mHealth’s efficient implementation.”
The process of residual analysis tests and proves (or disproves) the ability of the system to meet stressors for which it has not been designed. For those obvious stressors normally not included in a risk assessment, the process provides a method for analyzing how these stressors react when they occur in chains and eventually gives a sense of how the system behaves when exposed to stress in general.